The CDMO Expert

in Cell Therapy

Products

Cell-based therapies are not conventional Biologics,

they are living drugs…

…requiring cutting-edge expertise in Cell Culture.

0 +

Clinical Doses

manufactured in our state-of-the-art GMP facilities

0

Cell types

T cells, NK cells, T regs, MSCs, iPS cells, Macrophages, immortalized cell lines,…

0 +

Development Programs

Process Development, Optimization, Scale up.

Analytical & Potency test development.

0 +

ATMP Developers

TRUST US

from academic, to Biotech and Pharma companies

How SCIENCE plays out at Cell-Easy?

By combining solid technological and scientific knowledge in CELL CULTURE with conventional regulatory-controlled CDMO services, Cell-Easy’s multi-disciplinary team support you in transforming your laboratory proof-of-concept into a successful first-in-human clinical trial.

- 300+ cumulated years of cell culture experience
- Teams = PhDs, Engineers, Technicians in Cell Biology
- 70+ Technologies for Process & Analytics Development

- REGULATORY support adapted to cell products
- CMC driven by cell variability
- From concept to First-in-Human and beyond

- A dedicated Project Manager
- Co-define a robust roadmap
- Share Risks & Gaps during weekly meeting
- Avoid Change of Scope

- Accelerate Process Development/Scale-up with our Platforms
- Access expertise on 50+ different technologies
- Pre-established contract with providers

- Beyond agreements (NDA, MSA, QTA) our internal confidential policy protect your industrial secret
- As a fee for service CDMO, no IP is shared
- All documentation/production is Yours

- Respect TIMELINES
- Meet BUDGET
- Bring continous CMC and REGULATORY support
- Your SUCCESS is our goal

IUCT-Oncopole and Cell-Easy sign a MOU to accelerate cancer patient access to advanced cell-based therapy

TOULOUSE, FRANCE, June 22, 2023  IUCT-Oncopole and Cell-Easy SAS (Cell-Easy) announced today the signing of a Memorandum of Understanding to enhance their strategic collaborative relationship and open access to advanced cell-based therapies. This partnership aims to drive innovation in public health and improve access to promising new cancer therapies for patients.   By

Read More »

They Trust Us

Contact

Tel : +33 534 276 550
Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
Mail : info@cell-easy.com